Atlas Trials

Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas

Clinical trial NCT02755142 · COMPLETED

Trial details

NCT number
NCT02755142
Sponsor
medac GmbH
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Brain Neoplasm
Start date
2000-02-01
Primary completion
2001-06-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.